Alterity Therapeutics Files 6-K, Incorporates into Registrations
Ticker: PRNAF · Form: 6-K · Filed: Jul 17, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Jul 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: registration-statement, securities-application, procedural
Related Tickers: ATH
TL;DR
Alterity Therapeutics (ATH) filed a 6-K, linking it to existing S-8 and F-3 registrations. Standard procedural update.
AI Summary
Alterity Therapeutics Ltd. filed a Form 6-K on July 17, 2025, incorporating information into its existing Registration Statements on Form S-8 and Form F-3. The filing includes an application for quotation of securities under the ticker ATH.
Why It Matters
This filing is procedural, indicating Alterity Therapeutics is updating or maintaining its registration statements, which could impact the availability of its securities for future offerings or trading.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not appear to contain new material financial or operational information.
Key Players & Entities
- Alterity Therapeutics Ltd. (company) — Registrant
- ATH (company) — Ticker symbol for securities application
- July 17, 2025 (date) — Filing date
- Form S-8 (document) — Incorporated registration statement
- Form F-3 (document) — Incorporated registration statement
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is being incorporated by reference into Alterity Therapeutics Ltd.'s existing Registration Statements on Form S-8 and Form F-3.
What specific exhibit is included with this filing?
Exhibit 99.1, an application for quotation of securities for ATH, is submitted with this filing.
What are the file numbers for the Form S-8 registration statements mentioned?
The Form S-8 registration statements mentioned have file numbers 333-251073, 333-248980, and 333-228671.
What are the file numbers for the Form F-3 registration statements mentioned?
The Form F-3 registration statements mentioned have file numbers 333-274816, 333-251647, 333-231417, and 333-250076.
What is the principal executive office address of Alterity Therapeutics Limited?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 17, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).